Skip to main content

Animations

MJFF Publications

4671 - 4680 of 8654 Results
Title
Year
  • Year
  • 2011
  • 2012
  • 2018
  • 2011
  • 2014
  • 2014
  • 2016
  • 2005
  • 2016
  • 2011
  • Summary Details
    OPEN
    Title: CSF levels of oligomeric alpha-synuclein and beta-amyloid as biomarkers for neurodegenerative disease
    Journal Name: Integrative Biology
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1039/c1ib00018g
    Best OA location URL:
    Citation Count: 83
  • Summary Details
    OPEN
    Title: Increased risk of parkinsonism associated with welding exposure
    Journal Name: NeuroToxicology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuro.2012.08.011
    Citation Count: 153
  • Summary Details
    OPEN
    Title: Recent Advances in Cholinergic Imaging and Cognitive Decline—Revisiting the Cholinergic Hypothesis of Dementia
    Journal Name: Current Geriatrics Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s13670-018-0234-4
    Citation Count: 107
  • Summary Details
    OPEN
    Title: Subthalamic nucleus stimulation reverses mediofrontal influence over decision threshold
    Journal Name: Nature Neuroscience
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/nn.2925
    Best OA location URL:
    Citation Count: 658
  • Summary Details
    OPEN
    Title: Comparison of Parkinson Risk in Ashkenazi Jewish Patients With Gaucher Disease andGBAHeterozygotes
    Journal Name: JAMA Neurology
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1001/jamaneurol.2014.313
    Citation Count: 191
  • Summary Details
    OPEN
    Title: Genetic variability in the regulation of gene expression in ten regions of the human brain
    Journal Name: Nature Neuroscience
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/nn.3801
    Best OA location URL: http://doi.org/10.1038/nn.3801
    Citation Count: 656
  • Summary Details
    OPEN
    Title: Ade novocompound targeting α-synuclein improves deficits in models of Parkinson’s disease
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/aww238
    Citation Count: 137
  • Summary Details
    OPEN
    Title: Directed Differentiation of Dopaminergic Neuronal Subtypes from Human Embryonic Stem Cells
    Journal Name: STEM CELLS
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1634/stemcells.2004-0365
    Citation Count: 487
  • Summary Details
    OPEN
    Title: Heterogeneity of Treatment Response to Citalopram for Patients With Alzheimer’s Disease With Aggression or Agitation: The CitAD Randomized Clinical Trial
    Journal Name: American Journal of Psychiatry
    Publisher: American Psychiatric Association Publishing
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1176/appi.ajp.2015.15050648
    Citation Count: 86
  • Summary Details
    OPEN
    Title: Parkinson's disease induced pluripotent stem cells with triplication of the α-synuclein locus
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-sa
    DOI - Digital Object Identifier: 10.1038/ncomms1453
    Citation Count: 445
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.